Loss of anti-spike antibodies following mRNA vaccination for COVID-19 among patients with multiple myeloma.
Samuel David StampferSean BujarskiMarissa-Skye GoldwaterScott JewBernard RegidorHaiming ChenNing XuMingjie LiEddie FungRegina SwiftBethany BeattyShahrooz EshaghianJames R BerensonPublished in: Cancer reports (Hoboken, N.J.) (2023)
Thus, even MM patients who respond adequately to vaccination are likely to require more frequent booster doses than the general population.